Immunic, Inc.IMUXNASDAQ
LOADING
|||
EBITDA Over Time
Below historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-97.92M
↓ 59% below average
Average (9y)
$-61.70M
Historical baseline
Range
High:$-15.14M
Low:$-99.11M
CAGR
+7.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-97.92M | +1.2% |
| 2023 | $-99.11M | -14.7% |
| 2022 | $-86.44M | +5.6% |
| 2021 | $-91.58M | -87.2% |
| 2020 | $-48.93M | -32.3% |
| 2019 | $-36.98M | -144.3% |
| 2018 | $-15.14M | +70.4% |
| 2017 | $-51.08M | -30.4% |
| 2016 | $-39.16M | +22.8% |
| 2015 | $-50.70M | - |